GTBIF
Price
$8.27
Change
+$0.36 (+4.55%)
Updated
Sep 5 closing price
Capitalization
1.92B
TCNNF
Price
$7.58
Change
+$0.33 (+4.55%)
Updated
Sep 5 closing price
Capitalization
1.46B
60 days until earnings call
Interact to see
Advertisement

GTBIF vs TCNNF

Header iconGTBIF vs TCNNF Comparison
Open Charts GTBIF vs TCNNFBanner chart's image
Green Thumb Industries
Price$8.27
Change+$0.36 (+4.55%)
Volume$211.33K
Capitalization1.92B
Trulieve Cannabis
Price$7.58
Change+$0.33 (+4.55%)
Volume$309.56K
Capitalization1.46B
GTBIF vs TCNNF Comparison Chart in %
Loading...
GTBIF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TCNNF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GTBIF vs. TCNNF commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GTBIF is a Hold and TCNNF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (GTBIF: $8.27 vs. TCNNF: $7.58)
Brand notoriety: GTBIF and TCNNF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: GTBIF: 29% vs. TCNNF: 40%
Market capitalization -- GTBIF: $1.92B vs. TCNNF: $1.46B
GTBIF [@Pharmaceuticals: Generic] is valued at $1.92B. TCNNF’s [@Pharmaceuticals: Generic] market capitalization is $1.46B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $67.95B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.93B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GTBIF’s FA Score shows that 1 FA rating(s) are green whileTCNNF’s FA Score has 1 green FA rating(s).

  • GTBIF’s FA Score: 1 green, 4 red.
  • TCNNF’s FA Score: 1 green, 4 red.
According to our system of comparison, both GTBIF and TCNNF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GTBIF’s TA Score shows that 4 TA indicator(s) are bullish while TCNNF’s TA Score has 4 bullish TA indicator(s).

  • GTBIF’s TA Score: 4 bullish, 5 bearish.
  • TCNNF’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both GTBIF and TCNNF are a bad buy in the short-term.

Price Growth

GTBIF (@Pharmaceuticals: Generic) experienced а -4.83% price change this week, while TCNNF (@Pharmaceuticals: Generic) price change was -13.86% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.08%. For the same industry, the average monthly price growth was +12.00%, and the average quarterly price growth was +86.48%.

Reported Earning Dates

TCNNF is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+0.08% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GTBIF($1.92B) has a higher market cap than TCNNF($1.46B). TCNNF YTD gains are higher at: 46.233 vs. GTBIF (1.224). GTBIF has higher annual earnings (EBITDA): 338M vs. TCNNF (280M). TCNNF has more cash in the bank: 393M vs. GTBIF (177M). GTBIF has less debt than TCNNF: GTBIF (523M) vs TCNNF (824M). TCNNF (1.19B) and GTBIF (1.15B) have equivalent revenues.
GTBIFTCNNFGTBIF / TCNNF
Capitalization1.92B1.46B131%
EBITDA338M280M121%
Gain YTD1.22446.2333%
P/E Ratio75.18N/A-
Revenue1.15B1.19B97%
Total Cash177M393M45%
Total Debt523M824M63%
FUNDAMENTALS RATINGS
GTBIF vs TCNNF: Fundamental Ratings
GTBIF
TCNNF
OUTLOOK RATING
1..100
6913
VALUATION
overvalued / fair valued / undervalued
1..100
85
Overvalued
83
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9195
PRICE GROWTH RATING
1..100
4337
P/E GROWTH RATING
1..100
916
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TCNNF's Valuation (83) in the null industry is in the same range as GTBIF (85). This means that TCNNF’s stock grew similarly to GTBIF’s over the last 12 months.

TCNNF's Profit vs Risk Rating (100) in the null industry is in the same range as GTBIF (100). This means that TCNNF’s stock grew similarly to GTBIF’s over the last 12 months.

GTBIF's SMR Rating (91) in the null industry is in the same range as TCNNF (95). This means that GTBIF’s stock grew similarly to TCNNF’s over the last 12 months.

TCNNF's Price Growth Rating (37) in the null industry is in the same range as GTBIF (43). This means that TCNNF’s stock grew similarly to GTBIF’s over the last 12 months.

GTBIF's P/E Growth Rating (9) in the null industry is in the same range as TCNNF (16). This means that GTBIF’s stock grew similarly to TCNNF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GTBIFTCNNF
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
70%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
73%
Momentum
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 12 days ago
83%
Bullish Trend 10 days ago
78%
Declines
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
84%
Aroon
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
GTBIF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TCNNF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MINHX44.500.24
+0.54%
MFS International Intrinsic Value R4
BRSSX15.370.07
+0.46%
MFS Blended Research Small Cap Eq R2
PICMX63.29N/A
N/A
Virtus KAR Mid-Cap Growth I
SIPIX32.31N/A
N/A
SEI Mid-Cap I (SIMT)
GAORX22.12N/A
N/A
JPMorgan Global Allocation R5

GTBIF and

Correlation & Price change

A.I.dvisor indicates that over the last year, GTBIF has been closely correlated with CURLF. These tickers have moved in lockstep 82% of the time. This A.I.-generated data suggests there is a high statistical probability that if GTBIF jumps, then CURLF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GTBIF
1D Price
Change %
GTBIF100%
+4.55%
CURLF - GTBIF
82%
Closely correlated
+1.79%
TCNNF - GTBIF
82%
Closely correlated
+4.55%
VRNOF - GTBIF
79%
Closely correlated
+5.51%
TSNDF - GTBIF
77%
Closely correlated
+13.08%
CRLBF - GTBIF
71%
Closely correlated
+5.26%
More

TCNNF and

Correlation & Price change

A.I.dvisor indicates that over the last year, TCNNF has been closely correlated with GTBIF. These tickers have moved in lockstep 82% of the time. This A.I.-generated data suggests there is a high statistical probability that if TCNNF jumps, then GTBIF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TCNNF
1D Price
Change %
TCNNF100%
+4.55%
GTBIF - TCNNF
82%
Closely correlated
+4.55%
CURLF - TCNNF
78%
Closely correlated
+1.79%
VRNOF - TCNNF
76%
Closely correlated
+5.51%
CRLBF - TCNNF
76%
Closely correlated
+5.26%
TSNDF - TCNNF
75%
Closely correlated
+13.08%
More